Procalcitonin as diagnostic biomarker of sepsis

The Lancet Infectious Diseases

Volumn 13, Issue 5, 2013, Pages 382-384

  Afshari, Arash ^a,b   Harbarth, Stephan ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CLINICAL DECISION MAKING; DISEASE MARKER; DISEASE SEVERITY; LENGTH OF STAY; LETTER; MORTALITY; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEPSIS; TREATMENT RESPONSE;

CALCITONIN; HUMANS; PROTEIN PRECURSORS; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84876725232     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70026-4     Document Type: Letter

References (13)

1. Becker KL, Nylén ES, White JC, Müller B, Snider RH Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004, 89:1512-1525.
2. Reinhart K, Bauer M, Riedemann NC, Hartog CS New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev 2012, 25:609-634.
3. Harbarth S, Albrich WC, Müller B When once is not enough-further evidence of procalcitonin-guided antibiotic stewardship. Crit Care 2009, 13:165.
4. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006, 34:1996-2003.
5. Tang BM, Eslick GD, Craig JC, McLean AS Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007, 7:210-217.
6. Agarwal R, Schwartz DN Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review. Clin Infect Dis 2011, 53:379-387.
7. Schuetz P, Müller B, Christ-Crain M, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 2012, 9:CD007498.
8. Matthaiou DK, Ntani G, Kontogiorgi M, Poulakou G, Armaganidis A, Dimopoulos G An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients. Intensive Care Med 2012, 38:940-949.
9. Afshari A, Pagani L, Harbarth S Year in review 2011: critical care-infection. Crit Care 2012, 16:242.
10. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013, published online Feb 1. http://dx.doi.org/10.1016/S1473-3099(12)70323-7.
11. Fischer JE, Harbarth S, Agthe AG, et al. Quantifying uncertainty: physicians' estimates of infection in critically ill neonates and children. Clin Infect Dis 2004, 38:1383-1390.
12. Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010, 375:463-474.
13. Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008, 177:498-505.